concept

PARKINSON DISEASE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARKINSON DISEASE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

310Connections

1Hypotheses

12Analyses

50Outgoing

50Incoming

0Experiments

18Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	PARKINSON DISEASE
Key Genes/Proteins	ACHE, AD, AIF1, AKT, ALS, AMPK
Related Diseases	ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS
Related Pathways	APOPTOSIS

Pathway Diagram

graph TD
    PARKINSON_DISEASE["PARKINSON DISEASE"]
    PARKINSON_DISEASE -->|"risk_factor_for"| Dementia["Dementia"]
    PARKINSON_DISEASE -->|"causes"| Cognitive_Impairment["Cognitive Impairment"]
    Rotenone["Rotenone"] -->|"causes"| PARKINSON_DISEASE
    PRKN["PRKN"] -->|"risk_factor_for"| PARKINSON_DISEASE
    Mitochondrial_Dysfunction["Mitochondrial Dysfunction"] -->|"contributes to"| PARKINSON_DISEASE
    Vinpocetine["Vinpocetine"] -.protects against.-> PARKINSON_DISEASE
    Ageing["Ageing"] -->|"risk_factor_for"| PARKINSON_DISEASE
    Snca["Snca"] -.biomarker for.-> PARKINSON_DISEASE
    GBA["GBA"] -->|"risk_factor_for"| PARKINSON_DISEASE

Outgoing (72)

Target	Relation	Type	Str
Dementia Risk	risk_factor_for	phenotype	0.95
Dementia	risk_factor_for	disease	0.95
Dementia	causes	disease	0.95
Cognitive Impairment	causes	phenotype	0.92
Cognitive Decline	associated_with	phenotype	0.90
PD	activates	gene	0.60
PINK1	activates	gene	0.60
PD	co_discussed	gene	0.60
SQSTM1	activates	gene	0.60
SRC	activates	gene	0.60
STAT3	activates	gene	0.60
STING	activates	gene	0.60
TNF	activates	gene	0.60
TRAF6	activates	gene	0.60
ULK1	activates	gene	0.60
SNCA	co_discussed	gene	0.60
SNCA	activates	gene	0.60
TH	activates	gene	0.60
STING	co_discussed	gene	0.60
TAU	co_discussed	gene	0.60
SOD1	interacts_with	gene	0.60
SQSTM1	interacts_with	gene	0.60
STING	regulates	gene	0.60
TAU	interacts_with	gene	0.60
PD	mediates	gene	0.60
RAGE	associated_with	gene	0.60
TAU	associated_with	gene	0.60
TAU	enhances	gene	0.60
TFEB	co_discussed	gene	0.60
PD	markers	gene	0.60
PSEN1	inhibits	gene	0.60
VPS35	inhibits	gene	0.60
RIPK3	activates	gene	0.60
PD	causes	gene	0.60
SNCA	targets	gene	0.60
TAU	activates	gene	0.60
PARKINSON'S DISEASE	causes	disease	0.60
PINK1	causes	gene	0.60
PINK1	regulates	gene	0.60
PINK1	co_discussed	gene	0.60
RAGE	co_discussed	gene	0.60
PROGRESSIVE SUPRANUCLEAR PALSY	co_discussed	disease	0.60
SOD1	co_discussed	gene	0.60
SOD1	regulates	gene	0.60
SOD1	associated_with	gene	0.60
PD	disrupts	gene	0.60
PD	inhibits	gene	0.60
TFEB	inhibits	gene	0.60
VPS35	associated_with	gene	0.60
VPS35	regulates	gene	0.60

Incoming (238)

Source	Relation	Type	Str
entities-atp7b-gene	associated_with	wiki	0.00
LRRK2	causes	gene	0.95
PRKN	risk_factor_for	gene	0.95
Neural Mitochondrial Dysfunction	contributes_to	process	0.95
PINK1	associated_with	gene	0.95
Reactive Oxygen Species	contributes_to	process	0.95
GBA1	risk_factor_for	gene	0.95
Levodopa	treats	drug	0.95
Mitochondrial Dysfunction	contributes_to	process	0.95
Vinpocetine	protects_against	drug	0.95
LRRK2	risk_factor_for	gene	0.95
Ageing	risk_factor_for	process	0.95
SNCA	associated_with	gene	0.95
Rotenone	causes	compound	0.95
GBA	risk_factor_for	gene	0.95
Neuroinflammation	contributes_to	process	0.95
Snca	biomarker_for	biomarker	0.95
alpha-synuclein	causes	protein	0.90
23266198	increase the risk for developing	paper	0.90
LNK	associated_with	gene	0.90
PINK1	risk_factor_for	gene	0.90
23266198	increase risk for	paper	0.90
Oxidative Stress	contributes_to	process	0.90
SNCA	risk_factor_for	gene	0.90
NLRP3	involved_in	protein	0.90
Astrocytes	contributes_to	cell_type	0.90
GBA mutations	risk_factor_for	gene	0.90
GBA	contributes_to	gene	0.90
Hph-Rnpec	treats	drug	0.90
oxidative stress	associated_with	mechanism	0.90
COMT	associated_with	gene	0.90
Vinpocetine	treats	drug	0.90
Autophagy	involved_in	process	0.90
LRRK2	associated_with	gene	0.90
PBT434	treats	compound	0.90
NLRP3	risk_factor_for	gene	0.90
Kaempferol	protects_against	compound	0.90
LRRK2 G2019S	risk_factor_for	gene	0.90
Lysosomal Dysfunction	contributes_to	mechanism	0.90
TFEB	protective_against	gene	0.90
Ps1292-Lrrk2	biomarker_for	biomarker	0.88
G2019S-Lrrk2 Mutation	risk_factor_for	phenotype	0.88
HDAC6	associated_with	protein	0.85
Inflammasome	associated_with	pathway	0.85
Icariin	treats	compound	0.85
SNCA	biomarker_for	gene	0.85
MIRO1	associated_with	gene	0.85
PI3K/AKT/mTOR	associated_with	pathway	0.80
NLRP3	implicated_in	gene	0.80
LYSOSOMAL PROTEINS	causes	protein	0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Alpha-synuclein phosphorylation-dominated LLPS hijacks synap	0.657	parkinsons	-

Mentioning Analyses (12)

Scientific analyses that reference this entity

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

neurodegeneration | 2026-04-27 | 0 hypotheses

Microglial Priming as Upstream Causal Node Across AD, PD, ALS, MS: Three-Arm Cau

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

neurodegeneration | 2026-04-26 | 4 hypotheses Top: 0.630

Microglial senescence in Alzheimer and Parkinson disease progression

neurodegeneration | 2026-04-26 | 0 hypotheses

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.387

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (18)

Multi-agent debates referencing this entity

Is microglial priming (TREM2/CX3CR1/complement-C1q) genuinely causally upstream

closed · Rounds: 4 · Score: 0.64 · 2026-04-28

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

closed · Rounds: 6 · Score: 0.89 · 2026-04-27

Hypothesis debate: Microbial Inflammasome Priming Prevention

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

closed · Rounds: 4 · Score: 0.60 · 2026-04-26

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Microglial senescence in Alzheimer and Parkinson disease progression

closed · Rounds: 6 · Score: 0.50 · 2026-04-25

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

completed · Rounds: 5 · Score: 0.50 · 2026-04-25

Related Research

Hypotheses and analyses mentioning PARKINSON DISEASE in their description or question text

No additional research found

PARKINSON DISEASE

Understanding Entity Pages

Pathway Diagram

Outgoing (72)

Incoming (238)

Targeting Hypotheses (1)

Mentioning Analyses (12)

LRRK2 Risk Variants: Lysosomal Membrane Dynamics in DA vs Striatal Neurons

Microglial Priming as Upstream Causal Node Across AD, PD, ALS, MS: Three-Arm Cau

Gut-Brain Axis in Parkinson's Disease: Molecular Mechanisms, Neuroinflammation,

Microglial senescence in Alzheimer and Parkinson disease progression

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

Comparative epigenetic signatures: DNA methylation age acceleration and histone

Does RGS6 upregulation or D2 autoreceptor modulation prevent neurodegeneration i

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

How does engineered C. butyricum cross the blood-brain barrier to directly bind

How do different organelle-specific autophagy pathways coordinate during neurode

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

Experiments (0)

Related Papers (0)

Debates (18)

Is microglial priming (TREM2/CX3CR1/complement-C1q) genuinely causally upstream

How do GWAS-identified PD risk variants at the LRRK2 locus alter lysosomal membr

Hypothesis debate: Microbial Inflammasome Priming Prevention

Hypothesis debate: SCFA Deficiency Disrupts Microglial Homeostasis and Promotes

Hypothesis debate: Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propag

Hypothesis debate: Enteric Nervous System Dysfunction as Self-Reinforcing Pathol

Hypothesis debate: LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

What are the key molecular mechanisms by which gut microbiome dysbiosis drives n

Microglial senescence in Alzheimer and Parkinson disease progression

Epigenetic clocks as biomarkers for Alzheimer disease and neurodegeneration

Related Research